Role of Apolipoprotein E gene polymorphism in the risk of familial hypercholesterolemia: a case-control study

• Authors: Turky Almigbal , Mohammed Batais , Rana Hasanato , Fawaziah Alharbi , Imran Khan , Khalid Alharbi
• Languages of publication: EN

Abstracts

EN

Familial Hypercholesterolemia (FH) is characterized by elevated cholesterol and based on biochemical, clinical, and genetic studies and FH disease, which was documented even with limited mutations. Earlier studies focused on Apolipoprotein E (ApoE) in variable diseases. The current study aimed to investigate the genetic association between FH disease and ApoE gene polymorphisms (rs429358 and rs7412) in the Saudi population. This case-control study was a hospital-based study performed in Saudi Arabia. Two hundred and four subjects in total were recruited and consisted of FH participants (n=104) and the controls (n=100). Common polymorphisms of ApoE gene (rs429358 and rs7412) were chosen and subjected to the genotyping using the TaqMan assay. Moreover, the ApoE risk allele E4 was proved significantly associated with FH cases when compared with controls (OR-2.24 (95%CI: 1.06-4.70); p=0.02). Lipid profile parameters were significantly associated (p<0.05); however, the ApoE alleles and lipid profiles were not correlated (p>0.05). In conclusion, the FH case-control study was associated with the E4 allele in the Saudi population. However, E4 allele was appeared as a reliable risk marker for lipid profiles, but not for ApoE alleles.

Keywords

EN

familial hypercholesterolemia; ApoE gene; TaqMan assay; Saudi population.

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2018
• Volume: 65
• Issue: 3
• Pages: 415-420

Dates

published

2018

received

2017-10-24

revised

2018-06-28

accepted

2018-07-02

(unknown)

2018-09-15

Contributors

author

Turky Almigbal

• Department of Family and Community Medicine, King Saud University, Riyadh, Saudi Arabia

author

Mohammed Batais

• Department of Family and Community Medicine, King Saud University, Riyadh, Saudi Arabia

author

Rana Hasanato

• Department of Pathology College of Medicine and University Hospitals, King Saud University, Riyadh, Kingdom of Saudi Arabia

author

Fawaziah Alharbi

• Department of Biology Science, College of Science and Arts, Al-Qassim University, Al-Qassim, Saudi Arabia

author

Imran Khan

• Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, PO Box-10219, Riyadh-11433, Kingdom of Saudi Arabia

author

Khalid Alharbi

• Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, PO Box-10219, Riyadh-11433, Kingdom of Saudi Arabia

References

• Afroze D, Yousuf A, Tramboo NA, Shah ZA, Ahmad A (2016) ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population. Clinical and experimental medicine 16: 551-556. doi: 10.1007/s10238-015-0389-7.
• Agarwal R, Tripathi CB (2014) Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Am J Alzheimers Dis Other Demen 29: 575-582. doi: 10.1177/1533317514531443.
• Alallaf F, FA HN, Alnefaie M, Almaymuni A, Rashidi OM, Alhabib K, Alnouri F, Alama MN, Athar M, Awan Z (2017) The spectrum of familial hypercholesterolemia (FH) in Saudi Arabia: prime time for patient FH registry. Open Cardiovasc Med J 11: 66-75. doi: 10.2174/1874192401711010066.
• Al-Allaf FA, Alashwal A, Abduljaleel Z, Taher MM, Bouazzaoui A, Abalkhail H, Al-Allaf AF, Athar M (2017) Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient. Acta Biochim Pol 64: 75-79. doi: 10.18388/abp.2016_1283.
• Al-Allaf FA, Alashwal A, Abduljaleel Z, Taher MM, Siddiqui SS, Bouazzaoui A, Abalkhail H, Aun R, Al-Allaf AF, AbuMansour I, Azhar Z, Ba-Hammam FA, Khan W, Athar M (2016) Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children. Genomics 107: 24-32. doi: 10.1016/j.ygeno.2015.12.001.
• Al-Allaf FA, Athar M, Abduljaleel Z, Bouazzaoui A, Taher MM, Own R, Al-Allaf AF, AbuMansour I, Azhar Z, Ba-Hammam FA, Abalkhail H, Alashwal A (2014) Identification of a novel nonsense variant c.1332dup, p.(D445*) in the LDLR gene that causes familial hypercholesterolemia. Hum Genome Var 1: 14021. doi: 10.1038/hgv.2014.21.
• Al-Allaf FA, Athar M, Abduljaleel Z, Taher MM, Khan W, Ba-Hammam FA, Abalkhail H, Alashwal A (2015) Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease. Gene 565: 76-84. doi: 10.1016/j.gene.2015.03.064.
• Aledo R, Padro T, Mata P, Alonso R, Badimon L (2015) rs11613352 polymorphism (TT genotype) associates with a decrease of triglycerides and an increase of HDL in familial hypercholesterolemia patients. Rev Esp Cardiol (Engl Ed) 68: 305-309. doi: 10.1016/j.rec.2014.04.015.
• Alharbi KK, Alharbi FK, Alharbi FK, Ghneim HK, Al-Sulaiman A, Alodhayani AA, Tabassum SN, Khan IA (2016) Amendment of amino acid in Q192R genetic polymorphism of paraoxonase 1 is a conventional risk factor for type 2 diabetes mellitus in the Saudi population. Int J Clin Exp Med 9: 16605-16612.
• Alharbi KK, Kashour TS, Al-Hussaini W, Al-Nbaheen MS, Mohamed S, Hasanato RM, Tamimi W, Al-Naami MY, Khan IA (2013) Association of angiotensin converting enzyme gene insertion/deletion polymorphism and familial hypercholesterolemia in the Saudi population. Lipids Health Dis 12: 177. doi: 10.1186/1476-511x-12-177.
• Alharbi KK, Kashour TS, Al-Hussaini W, Nbaheen MS, Hasanato RM, Mohamed S, Tamimi W, Khan IA (2015) Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population. Acta Biochim Pol 62: 559-562. doi: 10.18388/abp.2015_1015.
• Alharbi KK, Khan IA, Syed R (2014) Association of apolipoprotein E polymorphism with type 2 diabetes mellitus in a Saudi population. DNA Cell Biol 33: 637-641. doi: 10.1089/dna.2014.2461.
• Angarica VE, Orozco M, Sancho J (2016) Exploring the complete mutational space of the LDL receptor LA5 domain using molecular dynamics: linking SNPs with disease phenotypes in familial hypercholesterolemia. Hum Mol Genet 25: 1233-1246. doi: 10.1093/hmg/ddw004.
• Arati S, Sibin MK, Bhat DI, Narasingarao KV, Chetan GK (2016) Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis. Meta Gene 9: 151-158. doi: 10.1016/j.mgene.2016.06.003.
• Awan Z, Choi HY, Stitziel N, Ruel I, Bamimore MA, Husa R, Gagnon MH, Wang RH, Peloso GM, Hegele RA, Seidah NG, Kathiresan S, Genest J (2013) APOE p.Leu167del mutation in familial hypercholesterolemia. Atherosclerosis 231: 218-222. doi: 10.1016/j.atherosclerosis.2013.09.007.
• Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 97: 3956-3964. doi: 10.1210/jc.2012-1563.
• Braenne I, Reiz B, Medack A, Kleinecke M, Fischer M, Tuna S, Hengstenberg C, Deloukas P, Erdmann J, Schunkert H (2014) Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia. BMC Cardiovasc Disord 14: 108. doi: 10.1186/1471-2261-14-108.
• Cao L, Wang K, Gu T, Du B, Song J (2014) Association between APOE epsilon 4 allele and postoperative cognitive dysfunction: a meta-analysis. Int J Neurosci 124: 478-485.
• Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J (1993) The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42: 895-901.
• Chan DC, Pang J, Barrett PHR, Sullivan DR, Burnett JR, van Bockxmeer FM, Watts GF (2016) ω-3 Fatty acid ethyl esters diminish postprandial lipemia in familial hypercholesterolemia. J Clin Endocrinol Metab 101: 3732-3739.
• Davignon J, Bouthillier D, Nestruck AC, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc 99: 100-110.
• Drogari E, Ragia G, Mollaki V, Elens L, Van Schaik RH, Manolopoulos VG (2014) POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia. Pharmacogenomics 15: 1963-1972. doi: 10.2217/pgs.14.138.
• Eto M, Watanabe K, Chonan N, Ishii K (1988) Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 72: 123-128.
• Fallaize R, Celis-Morales C, Macready AL, Marsaux CF, Forster H, O'Donovan C, Woolhead C, San-Cristobal R, Kolossa S, Hallmann J, Mavrogianni C, Surwillo A, Livingstone KM, Moschonis G, Navas-Carretero S, Walsh MC, Gibney ER, Brennan L, Bouwman J, Grimaldi K, Manios Y, Traczyk I, Drevon CA, Martinez JA, Daniel H, Saris WH, Gibney MJ, Mathers JC, Lovegrove JA (2016) The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial. Am J Clin Nutr 104: 827-836. doi: 10.3945/ajcn.116.135012.
• Friedlander Y, Leitersdorf E (1996) Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia. Genet Epidemiol 13: 159-177. doi: 10.1002/(SICI)1098-2272(1996)13:2<159::AID-GEPI3>3.0.CO;2-3.
• Futema M, Plagnol V, Li K, Whittall RA, Neil HA, Seed M, Bertolini S, Calandra S, Descamps OS, Graham CA, Hegele RA, Karpe F, Durst R, Leitersdorf E, Lench N, Nair DR, Soran H, Van Bockxmeer FM, Humphries SE (2014) Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations. J Med Genet 51: 537-544. doi: 10.1136/jmedgenet-2014-102405.
• Garatachea N, Marin PJ, Santos-Lozano A, Sanchis-Gomar F, Emanuele E, Lucia A (2015) The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis. Rejuvenation Res 18: 3-13. doi: 10.1089/rej.2014.1605.
• Gatt JM, Burton KL, Williams LM, Schofield PR (2015) Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res 60: 1-13. doi: 10.1016/j.jpsychires.2014.09.014.
• Graham CA, Latten MJ, Hart PJ (2017) Molecular diagnosis of familial hypercholesterolaemia. Curr Opin Lipidol 28: 313-320. doi: 10.1097/mol.0000000000000430.
• Gu L, Su L, Chen Q, Liang B, Qin Y, Xie J, Wu G, Yan Y, Long J, Wu H, Tan J, Dou W, Chen W, Wu P, Wang J (2013) Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis. Exp Ther Med 5: 853-859. doi: 10.3892/etm.2012.866.
• Haidich A-B (2010) Meta-analysis in medical research. Hippokratia 14: 29.
• Han Y, Liu T, Lu L (2013) Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis. Arch Med Res 44: 46-53.
• Hiddink L, Dallinga-Thie GM, Hovingh GK, de Visser MC, Peer PG, Stalenhoef AF, van Heerde WL (2015) Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease risk. Atherosclerosis 238: 195-200. doi: 10.1016/j.atherosclerosis.2014.11.023.
• Hinchcliffe M, Le H, Fimmel A, Molloy L, Freeman L, Sullivan D, Trent RJ (2014) Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting. Pathology 46: 60-68. doi: 10.1097/pat.0000000000000026.
• Ho CK, Musa FR, Bell C, Walker SW (2015) LDLR gene synonymous mutation c.1813C\>T results in mRNA splicing variation in a kindred with familial hypercholesterolaemia. Ann Clin Biochem 52: 680-684. doi: 10.1177/0004563215572702.
• Jensen HK (2002) The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Danish Medical Bulletin 49: 318-3145.
• Karahan Z, Ugurlu M, Ucaman B, Ulug AV, Kaya I, Cevik K, Ozturk O, Iyem H (2015) Relation between apolipoprotein e gene polymorphism and severity of coronary artery disease in acute myocardial infarction. Cardiol Res Pract 2015: 363458. doi: 10.1155/2015/363458.
• Katsanis SH, Katsanis N (2013) Molecular genetic testing and the future of clinical genomics. Nat Rev Genet 14: 415-426. doi: 10.1038/nrg3493.
• Khan IA, Vattam KK, Jahan P, Hasan Q, Rao P (2016) Importance of glucokinase -258G/A polymorphism in Asian Indians with post-transplant and type 2 diabetes mellitus. Intractable Rare Dis Res 5: 25-30. doi: 10.5582/irdr.2015.01040.
• Leduc V, Bourque L, Poirier J, Dufour R (2016) Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia. Pharmacogenet Genomics 26: 1-11. doi: 10.1097/fpc.0000000000000178.
• Li T, Shi Y, Yin J, Qin Q, Wei S, Nie S, Liu L (2015) The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis. Int Urol Nephrol 47: 117-130.
• Liao R, Ye M, Xu X (2014) An updated meta-analysis: apolipoprotein E genotypes and risk of primary open-angle glaucoma. Mol Vis 20: 1025-1036.
• Lin YJ, Pan JL, Jiang MJ, Tan JH, Zhong W, Gong TK, Jin XC, Cai SH, Wu YJ (2014) Apo E gene polymorphism affects development of type 2 diabetic nephropathy in Asian populations, especially in East Asians: an updated meta-analysis. Med Sci Monit 20: 1596-1603. doi: 10.12659/msm.892111.
• Liu M, Bian C, Zhang J, Wen F (2014) Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis. Scientific Reports 4: 4383. doi: 10.1038/srep04383.
• Lye SH, Chahil JK, Bagali P, Alex L, Vadivelu J, Ahmad WA, Chan SP, Thong MK, Zain SM, Mohamed R (2013) Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia. PLoS One 8: e60729. doi: 10.1371/journal.pone.0060729.
• Maurera F, Pradervandb S, Guilleretb I, Nanchend D, Maghraouib A, Chapatteb L, Bojkowskac K, Bhuiyana ZA, Jacquemontb N, Harshmanc K (2016) Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study. Swiss Med Wkly 146: w14326.
• Megale RZ, de Loyola Filho AI, Firmo JO, Lima-Costa MF, Peixoto SV (2016) Apolipoprotein E polymorphism and functional disability in Brazilian elders: the Bambui health and aging study. Cad Saude Publica 32: e00080115. doi: 10.1590/0102-311x00080115.
• Meng HX, Qi MG, Yi YY, Liu YP (2013) Association between apolipoprotein E gene polymorphism and the risk of recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet 30: 1547-1552.
• Miao J, Wang F, Zheng W, Zhuang X (2015) Association of the apolipoprotein E polymorphism with migraine: a meta-analysis. BMC Neurology 15: 138. doi: 10.1186/s12883-015-0385-2.
• Nikkola E, Ko A, Alvarez M, Cantor RM, Garske K, Kim E, Gee S, Rodriguez A, Muxel R, Matikainen N, Soderlund S, Motazacker MM, Boren J, Lamina C, Kronenberg F, Schneider WJ, Palotie A, Laakso M, Taskinen MR, Pajukanta P (2017) Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family. Atherosclerosis 264: 58-66. doi: 10.1016/j.atherosclerosis.2017.07.024.
• Nuglozeh E (2017) Whole-exomes sequencing delineates gene variants profile in a young Saudi male with familial hypercholesterolemia: case report. J Clin Diagn Res 11: Gd01-GD06. doi: 10.7860/jcdr/2017/28156.10143.
• Onorato A, Sturm AC (2016) Heterozygous familial hypercholesterolemia. Circulation 133: e587-e589.
• Pajak A, Szafraniec K, Polak M, Drygas W, Piotrowski W, Zdrojewski T, Jankowski P (2016) Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland. Arch Med Sci 12: 687.
• Paquette M, Dufour R, Baass A (2018) PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia. J Clin Lipidol. doi: 10.1016/j.jacl.2018.04.012.
• Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J (2015) Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population. BMC Med Genet 16: 86. doi: 10.1186/s12881-015-0230-x.
• Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517.
• Rubino E, Vacca A, Govone F, De Martino P, Pinessi L, Rainero I (2013) Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis. Alzheimer's Dementia 9: 706-713.
• Saavedra YG, Dufour R, Davignon J, Baass A (2014) PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Arterioscler Thromb Vasc Biol 34: 2700-2705. doi: 10.1161/atvbaha.114.304406.
• Salanti G, Sanderson S, Higgins JP (2005) Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7: 13-20. doi: 10.1097/01.gim.0000151839.12032.1a.
• Sanchez Munoz-Torrero JF, Rivas MD, Zamorano J, Alonso R, Joya-Vazquez P, Padro T, Mata P (2014) rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemia. J Clin Lipidol 8: 418-422. doi: 10.1016/j.jacl.2014.04.003.
• Stoumpos S, Hamodrakas SJ, Anthopoulos PG, Bagos PG (2013) The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls. J Hum Hypertens 27: 245-255. doi: 10.1038/jhh.2012.37.
• Sun JH, Tan L, Wang HF, Tan MS, Tan L, Li JQ, Xu W, Zhu XC, Jiang T, Yu JT (2015) Genetics of vascular dementia: systematic review and meta-analysis. J Alzheimers Dis 46: 611-629.
• Tada H, Kawashiri MA, Okada H, Endo S, Toyoshima Y, Konno T, Nohara A, Inazu A, Takao A, Mabuchi H, Yamagishi M, Hayashi K (2016) A rare coincidence of sitosterolemia and familial mediterranean fever identified by whole exome sequencing. J Atheroscler Thromb 23: 884-890. doi: 10.5551/jat.34827.
• Tian Y, Wang J, Ye Y, Sun L, Fan Y, Wang L, Li J, Wang Z, Wang K (2014) Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis. PLoS One 9: e102477. doi: 10.1371/journal.pone.0102477.
• Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H (1979) Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet 15: 37-62.
• van Lennep JER (2016) Knowledge equals health; why all healthcare professionals should know about familial hypercholesterolemia. Atherosclerosis 252: 188-189.
• Vandrovcova J, Thomas ER, Atanur SS, Norsworthy PJ, Neuwirth C, Tan Y, Kasperaviciute D, Biggs J, Game L, Mueller M, Soutar AK, Aitman TJ (2013) The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia. Genet Med 15: 948-957. doi: 10.1038/gim.2013.55.
• Versmissen J, Oosterveer DM, Yazdanpanah M, Dehghan A, Holm H, Erdman J, Aulchenko YS, Thorleifsson G, Schunkert H, Huijgen R, Vongpromek R, Uitterlinden AG, Defesche JC, van Duijn CM, Mulder M, Dadd T, Karlsson HD, Ordovas J, Kindt I, Jarman A, Hofman A, van Vark-van der Zee L, Blommesteijn-Touw AC, Kwekkeboom J, Liem AH, van der Ouderaa FJ, Calandra S, Bertolini S, Averna M, Langslet G, Ose L, Ros E, Almagro F, de Leeuw PW, Civeira F, Masana L, Pinto X, Simoons ML, Schinkel AF, Green MR, Zwinderman AH, Johnson KJ, Schaefer A, Neil A, Witteman JC, Humphries SE, Kastelein JJ, Sijbrands EJ (2015) Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach. Eur J Hum Genet 23: 381-387. doi: 10.1038/ejhg.2014.101.
• Wang W, Zhou M, Huang W, Chen S, Zhang X (2013) Lack of association of apolipoprotein E (Apo E) epsilon2/epsilon3/epsilon4 polymorphisms with primary open-angle glaucoma: a meta-analysis from 1916 cases and 1756 controls. PLoS One 8: e72644. doi: 10.1371/journal.pone.0072644.
• Wang Y, Zhou Y-F, Zhao B-Y, Gu Z-Y, Li S-L (2014) Apolipoprotein E gene ε4ε4 is associated with elevated risk of primary open angle glaucoma in Asians: a meta-analysis. BMC Med Genet 15: 60.
• Xu H, Li H, Liu J, Zhu D, Wang Z, Chen A, Zhao Q (2014) Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction. PLoS One 9: e104608. doi: 10.1371/journal.pone.0104608.
• Xu H, Qian Y, Guan J, Yi H, Yin S (2015) No association between the ApoE epsilon2 and epsilon4 alleles and the risk of obstructive sleep apnea: A systematic review and meta-analysis. Biomed Rep 3: 313-318. doi: 10.3892/br.2015.425.
• Yin Y-W, Qiao L, Sun Q-Q, Hu A-M, Liu H-L, Wang Q, Hou Z-Z (2014) Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies. Metabolism 63: 532-541.
• Yin Y-W, Sun Q-Q, Zhang B-B, Hu A-M, Liu H-L, Wang Q, Hou Z-Z (2013) Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies. PLoS One 8: e66924.
• Yin Y-W, Zhang Y-D, Wang J-Z, Li B-H, Yang Q-W, Fang C-Q, Gao C-Y, Li J-C, Zhang L-L (2012) Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects. Gene 511: 12-17.
• Yousuf FA, Iqbal MP (2015) Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. Pakistan J Pharmaceutical Sci 28: 1439-1444.
• Zeggini E, Ioannidis JP (2009) Meta-analysis in genome-wide association studies. Pharmacogenomics 10: 191-201. doi: 10.2217/14622416.10.2.191.
• Zhang C, Li S, Zhang X, Liu H, Luo Y (2015) Association of ApoE gene with type 2 diabetic nephropathy in a Chinese population: a meta-analysis of case-control studies. Annales d'Endocrinologie 76: 601-613. doi: 10.1016/j.ando.2014.12.001.
• Zhang M-d, Gu W, Qiao S-b, Zhu E-j, Zhao Q-m, Lv S-z (2014) Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls. PLoS One 9: e95463.
• Zhang R, Wang X, Tang Z, Liu J, Yang S, Zhang Y, Wei Y, Luo W, Wang J, Li J (2014) Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies. Lipids Health Dis 13: 47.
• Zhao D, Zhang Z, Wu GB, Wang HY, Gao F, Duan XD, Lu YY, Wang ZM, You DP, Qu Y, Song J (2016) Apolipoprotein E gene polymorphism and the risk of subarachnoid hemorrhage: a meta-analysis of case-control studies. Acta Neurochirurgica 158: 1515-1522. doi: 10.1007/s00701-016-2824-2.
• Zhu H, Xue H, Wang H, Ma Y, Liu J, Chen Y (2016) The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis. Minerva Cardioangiologica 64: 47-54.

Identifiers

DOI

10.18388/abp.2017_2344